Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant Research Letter

   

Authors:	DiNardo, C. D.; Stein, E. M.; Pigneux, A.; Altman, J. K.; Collins, R.; Erba, H. P.; Watts, J. M.; Uy, G. L.; Winkler, T.; Wang, H.; Choe, S.; Liu, H.; Wu, B.; Kapsalis, S. M.; Roboz, G. J.; de Botton, S.
Title:	Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant
Journal Title:	Leukemia
Volume:	35
Issue:	11
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Date Published:	2021-11-01
Start Page:	3278
End Page:	3281
Language:	English
DOI:	10.1038/s41375-021-01229-x
PUBMED:	33772143
PROVIDER:	scopus
PMCID:	PMC8464620
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103135624&doi=10.1038%2fs41375-021-01229-x&partnerID=40&md5=0a50f63955e41bcd95065fa12a7712b8
Notes:	Article -- Export Date: 1 December 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/190561